Back to search
Acute Lymphoblastic Leukaemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Lymphoblastic Leukaemia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Lymphoblastic Leukaemia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RAS genes. These mutations can cause the c…
This is a single-center, single-arm, observational clinical study evaluating the efficacy and safety of low-dose liposomal amphotericin B (50 mg/day, intravenou…
Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat people with relapsed B-ALL. For those who ach…
This phase II trial tests the effect of dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-EPOCH) with or without rituximab…
The goal of this study is to test an electronic health (eHealth) mindfulness-based music therapy intervention to improve health-related quality of life and redu…
The pilot study collects the experience of previously successful treatment of infants, children and young adults, with ALL from a number of well-renowned study…
Objectives: The primary objective of this study will be to evaluate the impact of pre-emptive use of anakinra on the rate of severe cytokine release syndrome (C…
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in…
Background: B-cell acute lymphoblastic leukemia (B-ALL) is a type of blood cancer. Some people with B-ALL have a gene mutation that makes the disease hard to t…